Evaluating the efficacy and safety of brolucizumab versus aflibercept on visual and anatomical outcomes in diabetic macular edema: a retrospective comparative study.

چکیده

The efficacy and safety of Aflibercept (AFL) 2 mg versus Brolucizumab (BRZ) 6 mg in diabetic macular edema (DME) were evaluated in this retrospective comparative research. Thirty-eight eyes with DME for > 18 months were retrospectively reviewed and divided equally. Group A received three loading…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• رتینوپاتی دیابتی
• درمان های ضد VEGF